A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?

European Urology - Tập 45 - Trang 539-546 - 2004
Gerhard Jakse1, Ferran Algaba2, Per-Uno Malmström3, Willem Oosterlinck4
1Urological Clinic, University Clinic of RWTH Aachen, Pauwelsstrasse 30, D-520570 Aachen, Germany
2Department of Pathology, Fundation Puigvert, Barcelona, Spain
3Department of Urology, University Hospital, Uppsala, Sweden
4Department of Urology, Universitair Ziekenhuis Gent, Ghent, Belgium

Tài liệu tham khảo

Herr, 1991, pT1 bladder cancer, Eur. Urol., 20, 1, 10.1159/000471649 Jakse, 1987, Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavourable tumor?, J. Urol., 137, 39, 10.1016/S0022-5347(17)43864-X Lutzeyer, 1982, Prognostic parameters in superficial bladder cancer: an analysis of 315 cases, J. Urol., 127, 250, 10.1016/S0022-5347(17)53725-8 Malmström, 1987, Recurrence, progression and survival in bladder cancer, Scand J. Urol. Nephrol., 21, 185, 10.3109/00365598709180320 Hall, 1992, Transurethral resection for transitional cell carcinoma, Problems in Urology, 6, 460 Soloway MS, Kurth KH, Herr H, Huland H, Denis L, Suzuki K, et al. Surgical techniques in the management of patients with superficial bladder cancer. In: Denis L, Niijima T, Prout G, Schröder FH. editors, Development in Bladder Cancer. Prog Clin Biol Res 1986;221:123–32. Milner, 1953, Results in the treatment of bladder tumors, J. Urol., 69, 657, 10.1016/S0022-5347(17)68127-8 Marberger, 1972, The current status of transurethral resection in the diagnosis and therapy of carcinoma of the urinary bladder, Int. Urol. Nephrol., 4, 35, 10.1007/BF02081891 Bressel M, Kemper K, Städtler. Vorbedingungen und Technik der transurethralen Elektroresektion des Harnblasenkarzinoms. Urologe 1969;8:73–80. Herr, 2001, Does cystoscopy correlate with histology of recurrent papillary tumours of the bladder?, BJU Int., 88, 83, 10.1046/j.1464-4096.2001.02396.x Pagano, 1991, Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopatholo-gical study with an emphasis on the inadequacy of the tumor, nodes and metastases classi-fication, J. Urol., 45, 45, 10.1016/S0022-5347(17)38244-7 Freeman, 1995, Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction, Cancer, 76, 833, 10.1002/1097-0142(19950901)76:5<833::AID-CNCR2820760518>3.0.CO;2-M Ameling, 1994, Radical cystectomy for stages Ta,Tis and T1 transitional cell carcinoma of the bladder, J. Urol., 151, 31, 10.1016/S0022-5347(17)34865-6 Cheng, 2000, Grading and staging of bladder carcinoma in transurethral resection specimens, Am. J. Clin. Pathol., 113, 275, 10.1309/94B6-8VFB-MN9J-1NF5 Dutta, 2000, Radical cystectomy in high risk non-muscle invasive transitional cell carcinoma indications and outcomes, J. Urol., 163, A662 Wijkström, 1998, Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term followup of 276 consecutive patients, Br. J. Urol., 81, 686, 10.1046/j.1464-410x.1998.00637.x Bernardini, 2001, The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma, J. Urol., 165, 42, 10.1097/00005392-200101000-00011 Smith, 1999, Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis), J. Urol., 162, 1697, 10.1016/S0022-5347(05)68208-0 Brausi, 2002, Variability in recurrence rate after at first follow-up cystoscopy after TUR in stage TaT1 transitional carcinoma of the bladder: A combined analysis of seven EORTC studies, Eur. Urol., 41, 523, 10.1016/S0302-2838(02)00068-4 Flamm, 1991, Stellenwert der differenzierten transurethralen Resektion beim primären oberflächlichen Harnblasnekarzinom, Urologe A, 30, 111 Zungri, 1999, T1 G3 bladder cancer, Eur. Urol., 36, 380, 10.1159/000020018 Klän, 1991, Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder, J. Urol., 146, 316, 10.1016/S0022-5347(17)37779-0 Brauers, 2001, 2nd Resection and prognosis in primary high risk superficial bladder cancer, J. Urol., 165, 808, 10.1016/S0022-5347(05)66532-9 Engelhardt, 2001, Die Wertigkeit der 2nd look transurethralen Elektroresektion beim oberflächlichen Blasenkarzinom, Akt Urol., 32, 173, 10.1055/s-2001-15848 Köhrmann, 1994, Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom, Akt Urol., 25, 208, 10.1055/s-2008-1058226 Schwaibold, 2000, Significance of 2nd transurethral resection for T1 bladder cancer, Eur. Urol., 37, 11 Schips, 2000, Is a second transurethral resection justified in patients with newly diagnosed superficial bladder cancer?, Eur. Urol., 37, 111 Koloszy, 1991, Histopathological “self control” in transurethral resection of bladder tumors, Br. J. Urol., 67, 162, 10.1111/j.1464-410X.1991.tb15100.x Althausen, 1976, Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ, J. Urol., 116, 575, 10.1016/S0022-5347(17)58916-8 Beisland, 1986, A propsective randomized study on neodym-YAG laser irradiation versus TUR in the treatment of urinary bladder cancer, Scand J. Urol. Nephrol., 20, 20, 10.3109/00365598609024496 Hellsten, 1981, Therapy of bladder carcinoma. Long-term results of a retrospective study of 214 cases, Scan J. Urol. Nephrol., 15, 115, 10.3109/00365598109179586 Lundbeck, 1989, Impact of the category of early tumor recurrence on tumor progression in bladder tumors treated by transurethral resection, Eur. Urol., 16, 291, 10.1159/000471594 Wolf, 1987, Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2), Scand J. Urol. Nephrol., 104, 127 Oosterlinck, 1993, A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta,T1 papillary carcinoma of the bladder, J. Urol., 149, 749, 10.1016/S0022-5347(17)36198-0 Tolley, 1988, Effect of intravesical mitomycin C on recurrence of newely diagnosed superficial bladder cancer: interim report from Medical Research Council Subgroup on Superficial Bladder Cancer, Br. Med. J., 96, 1759, 10.1136/bmj.296.6639.1759 Solsona, 1999, Effectiveness of a single immediate MMC instillation in patients with low risk superficial bladder cancer: short and long term follow-up, J. Urol., 161, 1120, 10.1016/S0022-5347(01)61606-9 Zaak D, Kriegmair M, Stepp H, Baumgartner, Obenender R, Schneede P. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 2001;57:690–4. Mulders, 1994, Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients, Eur. J. Cancer, 30, 914, 10.1016/0959-8049(94)90113-9 Pathologists of the French Association of Urology Cancer Committee. Lamina propria microinvasion of bladder tumors, incidence or stage allocation (pTa vs pT1): recommended approach. World J Urol 1993;11:161–4. Grigor KM, Bollina. Interpathologist variartion in the assessment of G3pT1 bladder carcinoma. Eur Urol 1996;30(Suppl 2):A850. Witjes, 1994, The influence of review pathology on study outcome of a randomized multicenter suprerficial bladder cancer trial, Br. J. Urol., 73, 172, 10.1111/j.1464-410X.1994.tb07487.x Meijden van der, 2000, The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 EORTC trials, J. Urol., 164, 1533, 10.1016/S0022-5347(05)67022-X Reuter, 1990, Pathology of bladder cancer: Assessment of prognostic variables and response to therapy, Semin. Oncol., 17, 524 Parmar, 1989, Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer. Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer, J. Urol., 142, 284, 10.1016/S0022-5347(17)38731-1 Kurth, 1995, Factors affecting recurrence and progression in superficial bladder tumors, Eur. J. Cancer, 31, 1840, 10.1016/0959-8049(95)00287-S Tosoni, 2000, Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer, BJU Int., 85, 48, 10.1046/j.1464-410x.2000.00356.x Angulo, 1995, Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer, Urology, 45, 47, 10.1016/S0090-4295(95)96490-8 Hasui, 1994, Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer, Urology, 43, 782, 10.1016/0090-4295(94)90134-1 Sözen, 2002, Microstaging of pT1 transitional cell carcinoma of the urinary bladder. Does it really differentiate two populations with different prognosis?, Urol. Int., 69, 200, 10.1159/000063941 Mersdorf, 1998, Second transurethral resection for superficial bladder cancer. A must?, J. Urol., 159, A143 Millan-Rodriguez, 2000, Multivariate analysisi of the prognostic factors of primary superficial bladder cancer, J. Urol., 163, 73, 10.1016/S0022-5347(05)67975-X Fitzpatrick, 1986, Superficial bladder tumors: the importance of recurrence pattern following initial resection, J. Urol., 135, 920, 10.1016/S0022-5347(17)45923-4 Müller, 1985, Exfoliative cytology after transurethral resection of superficial bladder tumours, Br. J. Urol., 57, 530, 10.1111/j.1464-410X.1985.tb05861.x Birch, 1989, The pT1G3 bladder tumour, Br. J. Urol., 64, 109, 10.1111/j.1464-410X.1989.tb05967.x Jewett, 1997, Appropriate restaging biopsies after initial resection or topical intravesical therapy, Atlas Urol. Clin. N. Am., 5, 15, 10.1016/S1063-5777(05)70063-3 Schrier, 2004, Prognosis of muscle invasive bladder cancer: difference between primary and progressive tumors: possible implications for therapy, Eur. Urol., 45, 292, 10.1016/j.eururo.2003.10.006 Schmidbauer, 2004, Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy, J. Urol., 171, 135, 10.1097/01.ju.0000100480.70769.0e